Nuron Biotech, Inc. — Form D
Nuron Biotech, Inc. of EXTON, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-12. The offering totals $35.7M, of which $22.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-02-12
- Form: D
- Accession: 0001565636-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $35.7M
- Amount sold: $22.7M
- Remaining: $13.0M
- Minimum investment: $10K
- Investors: 7
- Date of first sale: 2014-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-211834
Issuer
- Name: Nuron Biotech, Inc.
- CIK: 0001565636
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1 EAST UWCHLAN AVENUE, EXTON, PA, 19341
- Phone: 610 968 6700
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Gregory D Brown | Director | Charlotte, NC |
| Warren D Cooper | Director | Exton, PA |
| Todd D Davis | Director | Exton, PA |
| Vithalbhai D Dhaduk | Director | Exton, PA |
| Shankar Musunuri | Director | Malvern, PA |
| Mukeshbhai D Patel | Director | Exton, PA |
| Matthew Q Reber | Director | Exton, PA |
| David D Zeng, Ph.D. | Director | Exton, PA |
| Warren D Cooper | Executive Officer | Exton, PA |
| Wendy D DiCocco, CPA | Executive Officer | Exton, PA |
| Andrew L Romberger, Esq. | Executive Officer | Exton, PA |
| Gregory B Brown | Director | INDIANAPOLIS, IN |
| Shankar Musunuri | Executive Officer | Malvern, PA |
| Todd C Davis | Director | Stamford, CT |
| Wendy C DiCicco, CPA | Executive Officer | Exton, PA |
| David C Zeng, Ph.D. | Director | Exton, PA |
| David C Zeng, Ph.D. | Executive Officer | Exton, PA |
| Richard Dinovitz | Executive Officer | Exton, PA |
| Mark C Ambrose | Executive Officer | Exton, PA |
| Vijay Tammara, Ph.D. | Executive Officer | Exton, PA |
| Andrew Romberger, Esq. | Executive Officer | Exton, PA |
Other filings by this issuer (1)
More